The nurse hands you a small box with your name nowhere on it. "Try these for two weeks," she says. "If they work, we'll send in the prescription." You walk out feeling cared for. You also walk out without having been told the one number that will decide whether you can keep taking the medicine.

That number shows up fourteen days later, at a pharmacy counter, when the box is empty and the pharmacist says a figure you were never prepared for.

This is the quiet design flaw in free samples. They are not a lie, and the doctor who gives them is usually trying to help. But a sample answers the question "Does this drug work for me?" while skipping the question "Can I afford to keep taking it?" By the time the second question arrives, you are already attached.

Why free is a stronger price than it looks

Behavioral economists have a name for part of what happens here. In a well-known set of experiments by Shampanier, Mazar and Ariely, published in 2007 as "Zero as a Special Price," people did not treat free as just another low price. They treated it as a different category. Zero removed the sense of risk, and it made the free option feel disproportionately attractive compared with something that cost even a penny.

A sample is zero. For two weeks, the drug has no cost, no tradeoff, and no downside to weigh. So whatever the drug is, it gets judged in a world where money does not exist.

Then the world changes. Your brain does not compare the first real price to a neutral benchmark. It compares it to zero, and everything looks like a loss. Add the endowment effect, the tendency to value something more once it is yours, and the status quo bias, the preference for not changing a routine that is already working, and you have a person who feels they have to pay whatever is asked. Switching to something else feels like giving up progress.

None of this makes you irrational. It makes you human, standing at a counter with a symptom that finally improved.

What samples tend to be

Here is the structural piece. Free samples are overwhelmingly newer, brand-name products, because manufacturers are the ones who supply them. Generic makers, selling at thin margins, rarely have a reason to give away product. Research on prescribing patterns has repeatedly found that clinics with sample access lean toward newer, higher-priced drugs. The box on the shelf shapes what gets suggested first.

That does not mean the sample is the wrong drug. Sometimes the brand is the best option, or the only one. But it means that "what I was given" and "what is cheapest that works" are two separate questions, and the first one answered itself before you were asked.

It also means the real price is often unknown to the person who handed you the box. Doctors rarely see what a drug costs in cash at your particular pharmacy, and prices differ between pharmacies. Your clinician is not hiding it. They simply cannot see it from where they sit.

The reference point that changes the conversation

There is a public benchmark for the typical cost side of this. The Centers for Medicare & Medicaid Services publishes NADAC, the National Average Drug Acquisition Cost, based on surveys of what retail pharmacies pay to acquire drugs. It is not the price on your receipt. A pharmacy adds its own dispensing costs and margin. But it tells you roughly where a generic's price should start, which makes a $90 charge for something with a very low acquisition cost an obvious thing to question.

The benchmark matters most for the moment that follows the sample. If the drug you were handed has a generic version, the typical cost can fall dramatically. If it does not, you will at least know you are looking at a brand price and can plan for it, rather than being surprised by it.

The two-week window is your leverage

The best moment to deal with price is while the samples are still in your cabinet. You have time, you are not in withdrawal, and you are not choosing between a bill and a dose. After the box is empty, every option is urgent.

So treat the sample period as a trial of two things: the drug's effect, and its price. Both deserve a verdict before the last pill is gone.

Your next moves

  • Read the box today and write down two names. Find the brand name and the generic (active ingredient) name printed on the packaging. Search the generic name. If a generic exists, you now have a cheaper question to ask your doctor: "Can this be prescribed as the generic?"
  • Ask the clinic one question before you leave, or by portal message this week: "If this works, is there a generic or a lower-cost alternative in the same class, and what dose and quantity are you planning to prescribe?" Quantity matters, because a 30-day and a 90-day fill price very differently.
  • Price it before the prescription exists. Using the drug name, strength and quantity, check the typical national cost and then call two or three pharmacies for their cash price. Ask for the price for the exact strength and quantity, not a general range. Write the numbers down.
  • Count your remaining doses and set a date. If you have ten days of samples left, tell the clinic you want the prescription sent in about three days before they run out, so there is no gap and no panic fill at whatever price the nearest counter quotes.
  • If it is a brand with no generic, ask about manufacturer assistance. Many manufacturers run patient assistance programs, and some offer savings cards. Be careful: savings cards generally require commercial insurance and typically exclude people on government plans such as Medicare or Medicaid, while assistance programs often have income criteria instead. Ask your doctor's office, who usually know which ones exist, and check the manufacturer's site for the terms that apply to you.

None of these steps requires you to doubt your doctor. They just move the price question to the moment when you still have options.

When the price is still too high

Sometimes the answer is that the drug that worked is the one you cannot afford. That is a real and painful result, and it is far better to discover it in week one than in week three, with your symptoms returning. Tell your prescriber plainly. "This worked, and I cannot afford it" is a clinical fact, and it changes the plan in ways that a silent skipped refill never does. Do not stretch doses or quietly stop without telling them. The point of the early price check is to give your care team room to find another route.

The small shift underneath all of this

The sample period quietly teaches you to separate two questions that medicine usually bundles together: does it work, and what will it cost to keep working? Asking the second one early does not make you cheap, or difficult, or ungrateful for the box. It means that when the zero finally ends, the number you meet is one you already knew.

That is the only thing SnapRx is meant to do. You snap a photo of a prescription label, and it shows you the typical national cash price benchmark from CMS NADAC data and points you to real pharmacies nearby to call. It is a way to know the usual number before you fill, which is precisely the knowledge the sample box never gave you. If you are holding a half-empty box and a vague feeling about what comes next, you can try it at snaprx.lumenlabs.works. Either way, check the price while the pills are still free.